Navigation Links
Fighting Aussie yabbies don't forget a face -- new research by the University of Melbourne
Date:2/28/2008

The fighting Australian yabby does not forget the face of its foes says new research from University of Melbourne zoologists.

The research by the Universitys Department of Zoology has been published today in the PLoS ONE journal.

The two year study involving over 100 pairs of yabbies revealed that the species Cherax destructor is capable of facial recognition of individuals, particularly its opponents.

This is a remarkable capacity for the invertebrate species of yabbies and freshwater crayfish. This is an ability known in humans and some vertebrates but in only a handful of invertebrate species, said Professor David MacMillan, Head of the Department of Zoology who has led the research.

Yabbies usually fight when they meet. It is as much a way of meeting each other as a way of establishing territory.

Professor Macmillan said an understanding of how simple nervous systems recognise features may assist in developing feature recognition in robots.

In the study, after a fight, the loser yabby was isolated and given a choice between its opponent and another crayfish not involved in the fight.

The loser yabby moved towards the opponent it knew as opposed to the rival it did not, revealing that a yabby is capable of visual identity not just an acute sense of smell.

Careful observation by our team showed that the facial region is the important area for recognition of yabbies during and after a fight, Professor Macmillan said.

In particular we showed highly variable cues are used such as colour and face width.

Researchers also tested whether it is possible to engineer false identifications and whether animals can distinguish between twin opponents.

We continue to find the yabby is capable of more than we expected for an animal with such a simple nervous system and an invertebrate.

"Yabbies remember the smell of other crayfish but the extent to which they r
'/>"/>

Contact: Rebecca Scott
Rebeccas@unimelb.edu.au
61-383-440-181
University of Melbourne
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Social habits of cells may hold key to fighting diseases
2. When it comes fighting to C. difficile, the Palme dOr goes to soap and warm water
3. Fighting the spread of food poisoning
4. Gold nanorods shed light on new approach to fighting cancer
5. UV light improving chances of fighting cancer
6. Researchers uncover key trigger for potent cancer-fighting marine product
7. Fighting pollution the poplar way: Trees to clean up Indiana site
8. Fever causing headaches for Aussie parents
9. When accounting for the global nitrogen budget, dont forget fish
10. Research shows skeleton to be endocrine organ
11. Newly created cancer stem cells could aid breast cancer research

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fighting Aussie yabbies don't forget a face -- new research by the University of Melbourne
Fighting Aussie yabbies don't forget a face -- new research by the University of Melbourne
(Date:12/2/2009)...University Medical Center researchers have figured...glioma may be better able to resist radiation ther...ing pathway in these cancer stem cells, they were ... in a laboratory experiment. , The work builds ... cells resist the effects of radiation much better...
(Date:12/2/2009)...e smokeless tobacco product called moist snuff pl...nnesota to urge the tobacco industry to change man...carcinogens. Their study is published online in AC...y . It reports that this category of tobacco produ...oxic and cancer-causing substances. Called polycyc...
(Date:12/2/2009)...r muscles can twitch, before the thought telling i...te of sortscalled an ion channelmust open in the s...chemical signals that spur the cell to action. New...and Technology (NIST) has allowed scientists to ob... the first time, potentially offering insights for...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Nervy research: Researchers take initial look at ion channels in a model system 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18
...pidly distributing antibiotics to people,exposed t...ld by,itself, prevent about 70 percent of anthrax ...s from the Johns Hopkins Bloomberg School of,Publi...rcent, their,study found that at least 63 percent ...vaccine before an anthrax attack, which might not ...
... Southwestern Medical Center at Dallas,researchers...s of mice,to fight against amyloid proteins that c...ic of Alzheimer,s disease.,For years scientists ha...ed vaccine to slow the progression of the disease ...ave created a gene-based,vaccine aimed at stimulat...
...ientists have believed that neurons need a long pe...s before they take on their adult role. But after ...hese cells develop, a team of researchers at the S...eurons come into this world with a good idea about...is detailed in a paper in the March 24 issue of Ne...
Other Biology News:Study Models Impact Of Anthrax Vaccine 2Scientists identify molecular events that drive cell senescence 2First real-time view of developing neurons reveals surprises, say Stanford researchers 2
(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-As...mes; markets are in turmoil and uncertainty is par...that the pharma industry has been,relatively immun...t take a,vacation. , During the midst of ...giant Johnson & Johnson inaugurated an R&D...
(Date:12/1/2009)..., , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswi...: PDLI ) today announced revenue guidance for the...mately $57 million, as compared with $69 million f...quarter 2008 results was the first of two installm...included in fourth quarter 2008 results was a one-...
(Date:12/1/2009)..., , PLYMOUTH, Mass., Dec. 1 /PRNewswire/ -... ) announced today results from the company sponso...achandra Medical Center in Chennai, India using th...-reconstructable Critical Limb Ischemia (CLI). Sri...nternational-associated institution based in Chenn...
(Date:12/1/2009)..., , SARASOTA, Fla., Dec. 1 /PRNewswire/ ...ucts, Osprey Biotechnics Inc. of Sarasota has appo...distributor. ,, Lake is located near Birmingha...ficial bacteria which serve the agricultural, wast...re bred to be hungry and to open drain fields, and...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
... Celator Pharmaceuticals today,announced that Scot...o,present at the BIO Investor Forum in San Francis...and an update on the company,s clinical,developmen...sday, October,29, 2008 at 1:45 PM PDT in the Marin...pleased to announce that Dr. Arthur Louie, chief,m...
...Alfacell Corporation,(Nasdaq: ACEL ) today announ...scal year ended July 31, 2008, filed with the Secu...ncluded an audit opinion from its independent,regi... about the company,s,ability to continue as a goin...compliance with NASDAQ Marketplace Rule 4350(b)(1)...
...pril 27, 2009 to Regain Compliance with $1.00 ...IN, Calif., Oct. 23 Peregrine,Pharmaceuticals, In...tical,company developing monoclonal antibodies for...ons, today announced that it has received a letter...al time to regain,compliance with the minimum bid ...
Other Biology Technology:Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum 2Alfacell Receives Going Concern Audit Opinion 2Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2
Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Selenoprotein P Monoclonal Antibody, Unconjugated, Clone 35 from BD Biosciences Pharmingen
Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam
Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents
Biology Products: